- Radio Isotope Localization
- Radio Isotope Seed Localization (RSL)
- Radio Occult Lesion Localization (ROLL)
- Others
- Wire Guided localization
- Magnetic Tracker
- Others
Breast Lesion Localization Methods Market size was valued at USD 467.91 million in 2022 and is poised to grow at a CAGR of 6.6% from 2023-2029. Breast cancer is characterized by the abnormal multiplication of the breast cells that will form lumps that may be nonmalignant or malignant in nature. Such abnormal breast cells usually form tumors that may often observe on X-ray. Breast cancer occurs commonly in women above 40 years of age and often it can be seen in men also. For the early detection of lumps or lesions, various methods are used. Breast lesion localization methods are used to detect the nonpalatable suspicious breast lesions during the biopsy. The advent of novel technologies in breast localization methods such as electromagnetic reflectors and magnetic trackers and prevalence of the breast cancer worldwide are driving the breast lesion localization methods market. In addition, an increase in awareness about the early detection of breast cancer due to the different awareness campaigns and initiatives taken by the respective government and nonprofit organizations such as the Canadian Breast Cancer Foundation, American Cancer Society, and World Health Organization (WHO) expected to boost the market growth further. Moreover, favorable reimbursement policies in developed countries coupled with the rising demand for better healthcare infrastructure globally are projected to bolster market growth over the forecast period.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Breast cancer is one of the most common diseases that affect women in both developed and developing countries. Breast cancer is the second-leading cause of cancer-related deaths in women worldwide, according to the American Cancer Society. Globally, the number of breast cancer cases has increased significantly. This can be attributed primarily to changing lifestyles, increased use of oral contraceptives, and an increase in the number of women undergoing cosmetic surgeries such as breast enhancement. The risk of developing breast cancer rises with age. Aging increases the number of multipotent progenitors (a type of adult stem cell at the root of many breast cancers) while decreasing the number of myoepithelial cells, which line the milk-producing luminal cells of the breast and act as tumour suppressors. According to the American Cancer Society, one out of every eight invasive breast cancers develop in women under the age of 45. In contrast, approximately two out of every three invasive breast cancers occur in women aged 55 and up.
The breast lesion localization methods market size was valued at USD 467.91 million in 2022
The breast lesion localization methods market key players are Cianna Medical, Inc. (U.S.) STERYLAB (Italy) Cook Group Inc. (U.S.) SOMATEX Medical Technologies GmbH (Germany) CP Medical, Inc. (Theragenics Corporation) (U.S.) R. Bard, Inc. (U.S.) Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) (U.S.) Faxitron, Inc. (Faxitron Bioptics, LLC) (U.S.) Endomagnetics Limited. (UK)
North America is the fastest-growing breast lesion localization methods market